IL177596A0 - Inhalation formulations - Google Patents

Inhalation formulations

Info

Publication number
IL177596A0
IL177596A0 IL177596A IL17759606A IL177596A0 IL 177596 A0 IL177596 A0 IL 177596A0 IL 177596 A IL177596 A IL 177596A IL 17759606 A IL17759606 A IL 17759606A IL 177596 A0 IL177596 A0 IL 177596A0
Authority
IL
Israel
Prior art keywords
inhalation formulations
inhalation
formulations
Prior art date
Application number
IL177596A
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of IL177596A0 publication Critical patent/IL177596A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL177596A 2004-03-12 2006-08-21 Inhalation formulations IL177596A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN312MU2004 2004-03-12
PCT/GB2005/001119 WO2005087192A2 (en) 2004-03-12 2005-03-14 Salmeterol inhalation formulations

Publications (1)

Publication Number Publication Date
IL177596A0 true IL177596A0 (en) 2006-12-10

Family

ID=34962995

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177596A IL177596A0 (en) 2004-03-12 2006-08-21 Inhalation formulations

Country Status (9)

Country Link
EP (1) EP1732526A2 (en)
JP (1) JP2007528889A (en)
KR (1) KR20060135873A (en)
AP (1) AP2006003734A0 (en)
IL (1) IL177596A0 (en)
MA (1) MA28462B1 (en)
RU (1) RU2006136025A (en)
WO (1) WO2005087192A2 (en)
ZA (1) ZA200606801B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016052897A1 (en) * 2014-09-30 2016-04-07 Hanmi Pharm. Co., Ltd. Dry powder for inhalation formulation having improved stability of combined active ingredients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Pharmaceutical compositions comprising salmeterol and fluticasone propionate
GB2235627B (en) * 1989-09-08 1993-09-01 Glaxo Group Ltd Inhalation medicaments for treating respiratory disorders
EP1547636A1 (en) * 1995-04-14 2005-06-29 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
EP2319584A1 (en) * 2002-08-29 2011-05-11 Cipla Ltd. Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium

Also Published As

Publication number Publication date
RU2006136025A (en) 2008-04-20
JP2007528889A (en) 2007-10-18
AP2006003734A0 (en) 2006-10-31
WO2005087192A3 (en) 2006-06-15
WO2005087192A2 (en) 2005-09-22
KR20060135873A (en) 2006-12-29
EP1732526A2 (en) 2006-12-20
MA28462B1 (en) 2007-03-01
ZA200606801B (en) 2008-05-28

Similar Documents

Publication Publication Date Title
HUE032742T2 (en) Inhaler
GB0425305D0 (en) Bactericidal formulations
EP1981547A4 (en) Stable therapeutic formulations
IL181265A0 (en) Stabilizing formulations
EP1806148A4 (en) Medicinal composition for inhalation
GB0407990D0 (en) Inhaler
EP1862192A4 (en) Inhalator
GB0406288D0 (en) Respirators
GB0423800D0 (en) New pharmaceutical formulations
GB0406048D0 (en) Drug formulations
GB0423511D0 (en) Inhaler
IL177596A0 (en) Inhalation formulations
GB0419597D0 (en) Resuscitators
IL179208A0 (en) Intereferon formulations
GB0417226D0 (en) Formulations
GB0417248D0 (en) Formulations
HU0400157V0 (en) Inhalator
GB0426910D0 (en) Inhaler
GB0413081D0 (en) Inhaler
AP2007003999A0 (en) Inhaler
GB0424400D0 (en) Inhaler
ZA200409890B (en) Inhaler
GB0426292D0 (en) Novel formulations
GB0427248D0 (en) Novel formulations
GB0420818D0 (en) Novel formulations